<DOC>
	<DOCNO>NCT02979223</DOCNO>
	<brief_summary>The aim study compare efficacy depend order sequential combination method use sodium picosulfate magnesium citrate ( PMC ) PEG ascorbic acid bowel preparation . The investigator design study phase II prospective randomize parallel arm clinical trial . 67 participant enrol group ( 134 total ) . The primary outcome efficacy bowel preparation . secondary outcome tolerability , side effect drug , polyp detection rate adenoma detection rate .</brief_summary>
	<brief_title>Combination Method Using Sodium Picosulfate Magnesium Citrate PEG With Ascorbic Acid Bowel Preparation</brief_title>
	<detailed_description />
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Picosulfate sodium</mesh_term>
	<mesh_term>Magnesium citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Age : 2075 Patients visited outpatient clinic colonoscopy Patients agree participate study pregnancy , breast feeding stage 35 chronic kidney disease ( glomerular filtration rate &lt; 60 mL/min/1.73m2 ) , inability maintain adequate fluid intake , preexist electrolyte disturbance , symptomatic congestive heart failure , recent ( within &lt; 6 month ) symptomatic ischemic heart disease ( unstable angina myocardial infarction ) . toxic megacolon active colitis Allergic drug alter mental status Nausea vomit Hyperphosphatemia glucose6phosphate dehydrogenase deficiency Hereditary Phenylketonuria Patients history colon surgery Abdominal operation within 6 month</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>